Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study

PURPOSE: Benzodiazepines (BZDs) are prescribed to treat psychiatric diseases. However, many guidelines recommend limiting the use of BZDs because of side effects and lack of evidence regarding long-term efficacy. Moreover, reducing BZDs’ use is difficult because of dependency and the severity of wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Aiichiro, Kanie, Ayako, Ito, Masaya, Hirabayashi, Naotsugu, Imamura, Fumi, Takebayashi, Yoshitake, Horikoshi, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509325/
https://www.ncbi.nlm.nih.gov/pubmed/32982251
http://dx.doi.org/10.2147/NDT.S263537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509325/
https://www.ncbi.nlm.nih.gov/pubmed/32982251
http://dx.doi.org/10.2147/NDT.S263537

Ejemplares similares